SE343585B - - Google Patents

Info

Publication number
SE343585B
SE343585B SE17159/68A SE1715968A SE343585B SE 343585 B SE343585 B SE 343585B SE 17159/68 A SE17159/68 A SE 17159/68A SE 1715968 A SE1715968 A SE 1715968A SE 343585 B SE343585 B SE 343585B
Authority
SE
Sweden
Application number
SE17159/68A
Inventor
Douarec J Le
G Regnier
R Canevari
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of SE343585B publication Critical patent/SE343585B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE17159/68A 1967-12-29 1968-12-13 SE343585B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB58994/67A GB1193700A (en) 1967-12-29 1967-12-29 New Spiro (4,5) Decane Derivatives and Process for Preparing them

Publications (1)

Publication Number Publication Date
SE343585B true SE343585B (fr) 1972-03-13

Family

ID=10482850

Family Applications (1)

Application Number Title Priority Date Filing Date
SE17159/68A SE343585B (fr) 1967-12-29 1968-12-13

Country Status (7)

Country Link
US (1) US3594386A (fr)
AT (1) AT284858B (fr)
BE (1) BE725565A (fr)
CH (1) CH500224A (fr)
FR (2) FR348F (fr)
GB (1) GB1193700A (fr)
SE (1) SE343585B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790675A (fr) * 1971-10-29 1973-04-27 Science Union & Cie Nouveaux derives de l'oxa-1 diaza-3,8 spiro (4,5) decane
US4244961A (en) * 1978-10-26 1981-01-13 Syntex (U.S.A.) Inc. 1-Oxa-3,8-diazaspiro[4.5]decan-2-ones antihypertensive agents
US4255432A (en) * 1979-09-06 1981-03-10 Syntex (U.S.A.) Inc. 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof
ES517622A0 (es) * 1982-11-23 1983-12-16 Faes Procedimiento de preparacion de un nuevo espirodecano.
HU204530B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
HU204054B (en) * 1989-08-10 1991-11-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives and pharmaceutical compositions comprising same
US5739336A (en) * 1995-06-23 1998-04-14 Syntex (U.S.A.) Inc. 1,3,8-triaza- and 3,8-diaza-1-oxaspiro 4,5! decane derivatives
US20100279996A1 (en) * 2009-05-04 2010-11-04 Lindsay Burns Barbier Novel analgesic that binds filamin a
CN106458856A (zh) 2014-03-07 2017-02-22 约翰霍普金斯大学 组蛋白赖氨酸特异性的脱甲基酶(lsd1)和组蛋白脱乙酰基酶(hdac)的抑制剂
AU2017281222B2 (en) 2016-06-23 2022-06-16 The Usa As Represented By The Department Of Veterans Affairs; Dept. Of Veterans Affairs Office Of General Counsel - Pag Iv (024) Non-catalytic substrate-selective P38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
AU2019392904B9 (en) 2018-12-07 2022-12-22 University Of Maryland, Baltimore Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors
WO2021236449A1 (fr) * 2020-05-18 2021-11-25 Gen1E Lifesciences Inc. Inhibiteurs de protéine kinase p38alpha activée par mitogène
AU2021370893B2 (en) 2020-10-29 2024-03-07 Gen1E Lifesciences Inc. Crystalline 5-(dimethylamino) -n- (4-(morpholinomethyl)phenyl) naphthalene-1-sulfonamide di-hydrochloride di-hydrate
EP4313959A1 (fr) 2021-03-23 2024-02-07 GEN1E Lifesciences Inc. Inhibiteurs de protéine kinase p38alpha activée par mitogène substitués par naphtyle

Also Published As

Publication number Publication date
FR348F (fr) 1971-03-29
CH500224A (fr) 1970-12-15
FR96352E (fr) 1972-06-16
BE725565A (fr) 1969-06-16
GB1193700A (en) 1970-06-03
US3594386A (en) 1971-07-20
AT284858B (de) 1970-10-12
DE1815450A1 (de) 1969-09-04

Similar Documents

Publication Publication Date Title
AU425114B2 (fr)
FR348F (fr)
AU416737B2 (fr)
AU2277767A (fr)
AU342066A (fr)
AU610966A (fr)
AU2977667A (fr)
AU2116667A (fr)
AU2256867A (fr)
AU3189468A (fr)
AU2454867A (fr)
AU3151267A (fr)
AU2528767A (fr)
BE426053A (fr)
BE514578A (fr)
AU2406369A (fr)
AU1868267A (fr)
AU34866A (fr)
AU1763766A (fr)
AU1677166A (fr)
AU1614766A (fr)
AU459699A (fr)
AU23366A (fr)
AU97666A (fr)
BE162295A (fr)